Cytogenetics Technologists and Workforce- Private and Academic Collaboration to Sustain Expertise as Formal Training Programs get curtailed

Abstract Introduction/Objective Cancer Cytogenetics (CG) and Fluorescence in-situ Hybridization (FISH) testing are essential parts of molecular genetics (MG) in clinical diagnosis for patients suffering from hematopoietic disorders. Even though MG assays are clinically offered, and technical experti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of clinical pathology 2023-11, Vol.160 (Supplement_1), p.S20-S20
Hauptverfasser: Abbasi, A, Del Abra, V, Spranger, J, Ibraheem, R, Attili, S, Ehsan, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction/Objective Cancer Cytogenetics (CG) and Fluorescence in-situ Hybridization (FISH) testing are essential parts of molecular genetics (MG) in clinical diagnosis for patients suffering from hematopoietic disorders. Even though MG assays are clinically offered, and technical expertise is available, the need for expertise in CG and FISH cannot be understated. Due to budget constraints, deviated focus on innovation by academic programs and lack of awareness in the undergraduate programs, only a handful of centers offer formal training programs. Therefore, the need for qualified CG and FISH technologists to support the industry pipeline is continuously needed. Methods/Case Report With the increased workload and the need to combat workforce shortages, we continue to support academic centers as an on-site training facility. In addition, we have initiated academic collaborations with accredited training programs, both national and international, by training of our own technicians with a pilot program. These individuals hold bachelor’s degrees in biological sciences and are qualified to perform high-complexity testing under Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) regulations. Results (if a Case Study enter NA) Since 2009, we have had 32 qualified CG/FISH technologists with a CG (ASCP) board certification, most of whom graduated through academic programs. We took the initiative to train four staff members who acquired job experience while working in our CLIA/CAP accredited lab. After the ASCP year requirement was fulfilled, they became eligible to take the ASCP registry exam in CG. All four have passed and are certified cytogenetic technologists. Conclusion Challenged by a reduction in training programs and increasing demand in the industry, we have been successful in training and certifying our technologists with academic and private collaborations. More collaborative efforts are needed to fulfill such an important need in the field of CG.
ISSN:0002-9173
1943-7722
DOI:10.1093/ajcp/aqad150.044